Intravenous, but not intranasal (S15 Fig), administration of anti-TNF-α antibodies to mice significantly reduced pulmonary TNF-α levels and improved survival after the Delta P80 virus infection compared to control group, without affecting pulmonary viral load (S16 Fig). The gene discussed is TNF; the disease is viral infectious disease.